{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:18:11Z","timestamp":1792145891579,"version":"4.4.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH070855"],"award-info":[{"award-number":["MH070855"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MH071667"],"award-info":[{"award-number":["MH071667"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.neuropharm.2010.10.021","type":"journal-article","created":{"date-parts":[[2010,11,12]],"date-time":"2010-11-12T04:24:13Z","timestamp":1289535853000},"page":"1007-1016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":192,"title":["Epigenetic GABAergic targets in schizophrenia and bipolar disorder"],"prefix":"10.1016","volume":"60","author":[{"given":"A.","family":"Guidotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Auta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.P.","family":"Gavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.R.","family":"Grayson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Matrisciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Satta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.P.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Tremolizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tueting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2010.10.021_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ajmg.b.30140","article-title":"Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report","volume":"134B","author":"Abdolmaleky","year":"2005","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archpsyc.1995.03950160008002","article-title":"Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics","volume":"52","author":"Akbarian","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib3","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.neuron.2004.05.021","article-title":"Chromatin acetylation, memory, and LTP are impaired in CBP+\/\u2212 mice: a model for the cognitive deficit in Rubinstein\u2013Taybi syndrome and its amelioration","volume":"42","author":"Alarc\u00f3n","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nn.2447","article-title":"Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes","volume":"12","author":"Belforte","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0893-133X(01)00225-1","article-title":"GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder","volume":"25","author":"Benes","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1523\/JNEUROSCI.12-03-00924.1992","article-title":"Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics","volume":"12","author":"Benes","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib7","doi-asserted-by":"crossref","first-page":"10164","DOI":"10.1073\/pnas.0703806104","article-title":"Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars","volume":"104","author":"Benes","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-244X-9-71","article-title":"Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia","volume":"9","author":"Bitanihirwe","year":"2009","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0893-133X(00)00121-4","article-title":"Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia","volume":"23","author":"Breese","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.biopsych.2004.12.002","article-title":"Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions","volume":"57","author":"Browning","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib11","article-title":"Divalproex ER combined with olanzapine or risperidone for treatment of acute exacerbations of schizophrenia","author":"Casey","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib12","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1471-4159.2007.04797.x","article-title":"Induction of the reelin promoter by retinoic acid is mediated by Sp1","volume":"183","author":"Chen","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib13","article-title":"Analysis of the GAD1 promoter: trans-acting factors and DNA methylation converge on the 5\u2032 untranslated region","author":"Chen","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","article-title":"Multiple roles of HDAC inhibition in neurodegenerative conditions","volume":"32","author":"Chuang","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1006\/nbdi.2001.0436","article-title":"Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability","volume":"8","author":"Costa","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/mi.2.1.47","article-title":"Reelin and schizophrenia: a disease at the interface of the genome and the epigenome","author":"Costa","year":"2002","journal-title":"Mol. Interv."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4161\/epi.2.1.4063","article-title":"Reviewing the role of DNA (cytosine-5) methyltransferase overexpression in the cortical GABAergic dysfunction associated with psychosis vulnerability","volume":"2","author":"Costa","year":"2007","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib18","doi-asserted-by":"crossref","first-page":"27586","DOI":"10.1074\/jbc.M303740200","article-title":"Valproate induces replication-independent active DNA demethylation","volume":"278","author":"Detich","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib19","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1073\/pnas.0505394102","article-title":"Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia","volume":"102","author":"Dong","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib20","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1073\/pnas.0700529104","article-title":"Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters","volume":"104","author":"Dong","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib21","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1073\/pnas.0805493105","article-title":"Clozapine and sulpiride but not haloperidol or olanzapine activate nuclear DNA-demethylation in the brain","volume":"105","author":"Dong","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"8","key":"10.1016\/j.neuropharm.2010.10.021_bib22","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4161\/epi.5.8.13053","article-title":"Valproate induces DNA demethylation in nuclear extracts from adult mouse brain","volume":"5","author":"Dong","year":"2010","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jnr.20122","article-title":"GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia","volume":"76","author":"Dracheva","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.schres.2004.05.010","article-title":"Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons","volume":"73","author":"Eastwood","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib25","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/sj.mp.4000783","article-title":"Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression","volume":"5","author":"Fatemi","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib27","series-title":"Growth Arrest and DNA-Damage-Inducible, Beta (GADD45b) Expression and Function in the Brain: An Examination of a Putative Member of a DNA Demethylation Pathway Abnormally Expressed in Psychosis","author":"Gavin","year":"2010"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib28","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/sj.mp.4002062","article-title":"The pipeline and future of drug development in schizophrenia","volume":"12","author":"Gray","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib29","doi-asserted-by":"crossref","first-page":"9341","DOI":"10.1073\/pnas.0503736102","article-title":"Reelin promoter hypermethylation in schizophrenia","volume":"102","author":"Grayson","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib30","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pharmthera.2005.01.007","article-title":"The human reelin gene: transcription factors (+), repressors (\u2212) and the methylation switch (+\/\u2212) in schizophrenia","volume":"111","author":"Grayson","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib31","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archpsyc.57.11.1061","article-title":"Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study","volume":"57","author":"Guidotti","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-005-2212-8","article-title":"GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon","volume":"180","author":"Guidotti","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/WNR.0b013e32800fefd7","article-title":"S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis","volume":"18","author":"Guidotti","year":"2007","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tips.2008.10.010","article-title":"Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling","volume":"30","author":"Guidotti","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib35","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.biopsych.2005.01.010","article-title":"Analysis of pyramidal neuron morphology in an inducible knockout of brain derived neurotrophic factors","volume":"57","author":"Hill","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib36","doi-asserted-by":"crossref","first-page":"11254","DOI":"10.1523\/JNEUROSCI.3272-07.2007","article-title":"Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters","volume":"27","author":"Huang","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib37","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.95.26.15718","article-title":"A decrease of reelin expression as a putative vulnerability factor in schizophrenia","volume":"95","author":"Impagnatiello","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.med.58.060904.084114","article-title":"Schizophrenia: new pathological insights and therapies","volume":"58","author":"Jarskog","year":"2007","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib39","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"Jenuwein","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11126-006-7963-9","article-title":"Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia","volume":"77","author":"Kelly","year":"2006","journal-title":"Psychiatr. Q."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib41","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/nature08456","article-title":"DNA demethylation in hormone-induced transcriptional derepression","volume":"461","author":"Kim","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib42","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/mol.108.051763","article-title":"The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes","volume":"75","author":"Kundakovic","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib43","doi-asserted-by":"crossref","first-page":"40545","DOI":"10.1074\/jbc.M402229200","article-title":"Regulation of histone acetylation during memory formation in the hippocampus","volume":"279","author":"Levenson","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib44","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbagrm.2008.01.001","article-title":"The role of reelin in adult synaptic function and the genetic and epigenetic regulation of the reelin gene","volume":"1779","author":"Levenson","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.npp.1301563","article-title":"Neuroplasticity of neocortical circuits in schizophrenia","volume":"33","author":"Lewis","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib46","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2010.10.021_bib47","first-page":"1","article-title":"Grand challenges and opportunities for molecular psychiatry research: a perspective","volume":"1","author":"Li","year":"2010","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib48","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/hmg\/ddl040","article-title":"Expression of DISC1 binding partners is reduced in schizophrenia and is associated with DSC1 SNPs","volume":"15","author":"Lipska","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib49","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","article-title":"Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia","volume":"31","author":"Lisman","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","article-title":"Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action","volume":"58","author":"Loscher","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib51","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1166859","article-title":"Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis","volume":"323","author":"Ma","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib52","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0896-6273(00)80239-1","article-title":"Neurotrophin regulation of cortical dendritic growth requires activity","volume":"17","author":"McAllister","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib53","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ajhg.2008.01.008","article-title":"Epigenomic profiling reveals DNA-methylation changes associated with major psychosis","volume":"82","author":"Mill","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib54","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1126\/science.329.5991.502","article-title":"Is pharma running out of brainy ideas?","volume":"329","author":"Miller","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib55","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2007.02.022","article-title":"Covalent modification of DNA regulates memory formation","volume":"1533","author":"Miller","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib56","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nn.2560","article-title":"Cortical DNA methylation maintains remote memory","volume":"13","author":"Miller","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib57","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1471-4159.2005.03040.x","article-title":"Histone deacetylase inhibitors decrease reelin promoter methylation in vitro","volume":"93","author":"Mitchell","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib58","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(03)00757-8","article-title":"Bringing order to the glutamate chaos in schizophrenia","volume":"20","author":"Moghaddam","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib59","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1073\/pnas.0409648102","article-title":"DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures","volume":"102","author":"Noh","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cell.2008.06.009","article-title":"The colorful history of active DNA demethylation","volume":"133","author":"Ooi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib61","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1126\/science.1186088","article-title":"Altered histone acetylation is associated with age-dependent memory impairment in mice","volume":"328","author":"Peleg","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib62","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.pharmtox.48.113006.094731","article-title":"Epigenetics and complex disease: from etiology to new therapeutics","volume":"48","author":"Ptak","year":"2008","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib63","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1523\/JNEUROSCI.5284-09.2010","article-title":"Reelin regulates postnatal neurogenesis and enhances spine hypertrophy and long-term potentiation","volume":"30","author":"Pujadas","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib64","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/hmg\/4.suppl_1.1751","article-title":"DNA methylation in early development","volume":"4","author":"Razin","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib65","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd1346","article-title":"Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia","volume":"3","author":"Roth","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib66","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bbagen.2009.06.009","article-title":"Epigenetic mechanisms in schizophrenia","volume":"1790","author":"Roth","year":"2009","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib67","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.mp.4001954","article-title":"Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection","volume":"12","author":"Ruzicka","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib68","doi-asserted-by":"crossref","first-page":"16356","DOI":"10.1073\/pnas.0808699105","article-title":"Nicotine targets the epigenetic mechanisms in selected populations of mouse\u00a0telencephalic GABAergic neurons","volume":"105","author":"Satta","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib69","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.schres.2007.09.020","article-title":"Histone deacetylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection","volume":"98","author":"Sharma","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib70","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1371\/journal.pgen.0040028","article-title":"Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women","volume":"4","author":"Shifman","year":"2008","journal-title":"PLoS Genet."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib71","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1073\/pnas.0510341103","article-title":"The benzamide MS-275 is a potent long-lasting brain region-selective inhibitor of histone deacetylases","volume":"103","author":"Simonini","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib72","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/sj.mp.4001988","article-title":"Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression","volume":"12","author":"Straub","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib73","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/mp.2008.25","article-title":"Genomewide association for schizophrenia in the CATIE study: results of stage 1","volume":"13","author":"Sullivan","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib74","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10541-005-0147-7","article-title":"DNA methylation and demethylation as targets for anticancer therapy","volume":"70","author":"Szyf","year":"2005","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib75","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biopsych.2004.11.046","article-title":"Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice","volume":"57","author":"Tremolizzo","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib76","doi-asserted-by":"crossref","first-page":"17095","DOI":"10.1073\/pnas.262658999","article-title":"An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability","volume":"99","author":"Tremolizzo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib77","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00001756-199904260-00032","article-title":"The phenotypic characteristics of heterozygous reeler mouse","volume":"10","author":"Tueting","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib78","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/WNR.0b013e3283373126","article-title":"L-methionine decreases dendritic spine density in mouse frontal cortex","volume":"21","author":"Tueting","year":"2010","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib79","series-title":"Epigenetics","first-page":"23","article-title":"DNA methyltransferases and methyl CpG binding proteins as multifunctional regulators of chromatin structure and development in mammalian cells","author":"Van Emburgh","year":"2008"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib80","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1073\/pnas.2637013100","article-title":"DNA methyltransferase-1 (DNMT1) is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains","volume":"101","author":"Veldic","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib81","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1073\/pnas.0409665102","article-title":"In psychosis, cortical interneurons overexpress DNA-methyltransferase 1","volume":"102","author":"Veldic","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib82","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.schres.2006.11.029","article-title":"Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder","volume":"91","author":"Veldic","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib83","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00004714-200006000-00011","article-title":"Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia","volume":"20","author":"Wassef","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib84","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1073\/pnas.0507526103","article-title":"Maternal care effects on the hippocampal transcriptome and anxiety mediated behaviors in the offspring that are reversible in the adulthood","volume":"103","author":"Weaver","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib85","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/sj.mp.4002047","article-title":"Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families","volume":"13","author":"Wedenoja","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib86","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archpsyc.61.7.649","article-title":"Density of glutamic acid decarboxylase67 messenger RNA-containing neurons that express n-methyl-d-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder","volume":"61","author":"Woo","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib87","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.biopsych.2008.04.034","article-title":"N-methyl-d-aspartate receptor and calbindin-containing neurons in the anterior cingulate cortex in schizophrenia and bipolar disorder","volume":"64","author":"Woo","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2010.10.021_bib88","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/schbul\/1.4.10","article-title":"Biochemical and sleep studies of schizophrenia. A review of the literature 1960\u20131970","volume":"4","author":"Wyatt","year":"1971","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib89","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev-genet-102108-134205","article-title":"Active DNA demethylation mediated by DNA glycosylases","volume":"43","author":"Zhu","year":"2009","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2010.10.021_bib90","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.schres.2009.03.020","article-title":"An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes","volume":"111","author":"Zhubi","year":"2009","journal-title":"Schizophr. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810002911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390810002911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:42:00Z","timestamp":1758436920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390810002911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":89,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0028390810002911"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2010.10.021","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic GABAergic targets in schizophrenia and bipolar disorder","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2010.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}